Neoleukin Therapeutics (NLTX) Ownership

0.60 ↑0.02 (3.02%)
As of January 31, 2023, 3:48pm EST.

Institutional Ownership

Baker Bros Advisors LP is the biggest individual institutional holder of Neoleukin Therapeutics (NLTX), owning a total of 3.8 million shares. Combined, the top 22 institutional holders of NLTX own 42.80% of the company with a total of 18.2 million shares.

In the latest ownership report on September 30th 2022, the top 22 institutional holders decreased their combined ownership of NLTX by 27 thousand shares. 4 institutions bought 781,068 total additional shares and increased their ownership by an average of 13.77%. However 9 institutions sold 808,381 total shares and decreased their ownership by an average of 7.89%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Neoleukin Therapeutics decreased by a net total of -27,313 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP8.972%0.000%3,821,74002022-09-30
Redmile Group, LLC8.069%0.000%3,436,93502022-09-30
Point72 Asset Management, L.P.4.846%43.606%2,064,222626,8052022-09-30
Millennium Management LLC3.980%-19.883%1,695,383-420,7602022-09-30
Renaissance Technologies Corp3.386%-10.667%1,442,067-172,1932022-09-30
Vanguard Group Inc2.409%-8.664%1,025,886-97,3192022-09-30
BlackRock Inc2.088%-2.364%889,298-21,5342022-09-30
Morgan Stanley - Brokerage Accounts1.391%-4.885%592,461-30,4312022-09-30
Opaleye Management Inc1.350%-5.738%575,000-35,0002022-09-30
Two Sigma Advisers, LLC0.925%1.651%394,0006,4002022-09-30
Two Sigma Investments LLC0.806%9.813%343,13630,6632022-09-30
Geode Capital Management, LLC0.709%0.000%301,78302022-09-30
ACT Capital Management, LLC0.467%0.000%199,00002022-09-30
Bank of America Corp0.413%-6.476%175,862-12,1782022-09-30
Ergoteles LLC0.355%-8.818%151,320-14,6332022-09-30
Royce & Associates, LP0.341%0.000%145,39702022-09-30
State Street Corporation0.288%0.000%122,55602022-09-30
Kynam Capital Management, LP0.283%-3.475%120,368-4,3332022-09-30
Privium Fund Management (UK) Ltd0.275%0.000%117,200117,2002022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP8.972%0.000%3,821,74002022-09-30
Redmile Group, LLC8.069%0.000%3,436,93502022-09-30
Point72 Asset Management, L.P.4.846%43.606%2,064,222626,8052022-09-30
Millennium Management LLC3.980%-19.883%1,695,383-420,7602022-09-30
Renaissance Technologies Corp3.386%-10.667%1,442,067-172,1932022-09-30
Vanguard Group Inc2.409%-8.664%1,025,886-97,3192022-09-30
BlackRock Inc2.088%-2.364%889,298-21,5342022-09-30
Morgan Stanley - Brokerage Accounts1.391%-4.885%592,461-30,4312022-09-30
Opaleye Management Inc1.350%-5.738%575,000-35,0002022-09-30
Barclays PLC1.062%-1.248%452,250-5,7172022-06-30
Two Sigma Advisers, LLC0.925%1.651%394,0006,4002022-09-30
Two Sigma Investments LLC0.806%9.813%343,13630,6632022-09-30
Geode Capital Management, LLC0.709%0.000%301,78302022-09-30
ACT Capital Management, LLC0.467%0.000%199,00002022-09-30
Bank of America Corp0.413%-6.476%175,862-12,1782022-09-30
Ergoteles LLC0.355%-8.818%151,320-14,6332022-09-30
Royce & Associates, LP0.341%0.000%145,39702022-09-30
State Street Corporation0.288%0.000%122,55602022-09-30
Kynam Capital Management, LP0.283%-3.475%120,368-4,3332022-09-30
Privium Fund Management (UK) Ltd0.275%0.000%117,200117,2002022-09-30
JPMorgan Chase & Co0.201%209.995%85,51257,9272022-06-30
Citadel Advisors Llc0.187%290.865%79,50259,1622022-06-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Neoleukin Therapeutics (NLTX), owning a total of 494 thousand shares. Combined, the top 23 mutual fund holders of NLTX own 7.92% of the company with a total of 3.4 million shares.

In the latest ownership report on December 31st 2022, the top 23 fund holders increased their combined ownership of NLTX by 389 shares. 2 funds bought 887 total additional shares and increased their ownership by an average of 0.41%. However 1 funds sold 498 total shares and decreased their ownership by an average of 0.74%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Neoleukin Therapeutics increased by a net total of 389 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv1.159%0.000%493,54002022-12-31
Vanguard Extended Market Index Investor1.124%0.152%478,8387262022-12-31
BlackRock Extended Equity Market K0.158%-0.735%67,226-4982022-12-31
NT Ext Equity Mkt Idx Fd - NL0.070%0.000%29,62202022-12-31
Vanguard Instl Ttl Stk Mkt Idx InstlPls0.058%0.000%24,54202022-12-31
NT Ext Equity Mkt Idx Fd - DC - NL - T20.057%0.674%24,0481612022-12-31
NT Ext Equity Mkt Idx Fd - L0.054%0.000%23,15802022-12-31
State St US Extended Mkt Indx NL Cl C0.035%0.000%15,05302022-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv1.159%0.000%493,54002022-12-31
Vanguard Instl Ttl Stck Mkt Idx Tr1.159%-16.471%493,540-97,3192022-09-30
Vanguard Extended Market Index Investor1.124%0.152%478,8387262022-12-31
Pictet-Biotech P USD1.101%-55.813%469,084-592,5022022-06-30
iShares Biotechnology ETF0.627%-0.153%267,088-4102022-11-30
Pictet-Global Megatrend Sel I USD0.561%-59.716%238,900-354,1392022-06-30
Fidelity® Extended Market Index0.412%0.000%175,36002022-11-30
Royce Micro Cap Trust0.341%0.000%145,39702022-09-30
BlackRock Extended Mkt Composite0.180%0.000%76,70302022-09-30
Bridgeway Ultra-Small Company Market0.176%0.000%75,00075,0002022-09-30
iShares Micro-Cap ETF0.167%0.000%71,06602022-12-30
BlackRock Extended Equity Market K0.158%-0.735%67,226-4982022-12-31
iShares Core S&P Total US Stock Mkt ETF0.122%0.000%52,08902022-12-30
Fidelity® Total Market Index0.113%0.000%48,24802022-11-30
Fidelity® Series Total Market Index0.087%0.000%36,96802022-11-30
NT Ext Equity Mkt Idx Fd - NL0.070%0.000%29,62202022-12-31
Vanguard Instl Ttl Stk Mkt Idx InstlPls0.058%0.000%24,54202022-12-31
NT Ext Equity Mkt Idx Fd - DC - NL - T20.057%0.674%24,0481612022-12-31
NT Ext Equity Mkt Idx Fd - L0.054%0.000%23,15802022-12-31
Northern Trust Extended Eq Market Idx0.054%0.000%23,15802022-09-30
Fidelity® NASDAQ Composite Index®0.053%0.000%22,52902022-11-30
T. Rowe Price U.S. Equities Tr0.048%0.000%20,30002022-09-30
State St US Extended Mkt Indx NL Cl C0.035%0.000%15,05302022-12-31

Discussions

Please log in or register to share your thoughts.

im_drank

$NLTX the greatest stock of all time
will not bow to the shorts
oh yeah

0 Like Report